Otezla (apremilast) prior authorization denied appeal
PDE4 inhibitor for PsO, PsA, Behçet's oral ulcers
Typical PA criteria
- Approved indication with ICD-10
- Prior topical or phototherapy trial for PsO
- Specialist prescriber
- Renal dose adjustment reviewed
Why your PA was denied
- Prior topical/phototherapy trial not documented
- Non-specialist prescriber
- Renal function not addressed
- Non-preferred formulary status
Evidence that overturns the denial
- ✓PASI, BSA, or joint count at baseline
- ✓Prior topical or phototherapy trial dates
- ✓eGFR documented
- ✓Dermatology or rheumatology letter
Oral therapy; useful when biologics are declined or contraindicated. Weight loss is a labeled side effect — flag baseline weight.
Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.
FAQ
Why was my Otezla (apremilast) prior authorization denied?+
The most common reasons are: Prior topical/phototherapy trial not documented; Non-specialist prescriber; Renal function not addressed. Your denial letter names the specific criteria you did not meet.
How do I appeal a Otezla (apremilast) denial?+
File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.
What evidence overturns a Otezla (apremilast) denial?+
PASI, BSA, or joint count at baseline; Prior topical or phototherapy trial dates; eGFR documented.
What if the plan excludes Otezla (apremilast) entirely?+
Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.
Other drugs
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Saxenda (liraglutide)